← Back to patent-cliff list
CAS 17159-79-4
4-Oxocyclohexanecarboxylic acid ethyl ester
Codes：(V)409139-9-a
Application context (from source-drug indications)
转甲状腺素运载蛋白淀粉样变性氯苯唑酸心脏病氯苯唑酸
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 氯苯唑酸Tafamidis | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-Ethyl-3-hydroxybenzene→(3,5-Dichlorophenyl)methanamine→2-(3,5-Dichlorophenyl)-6-ethyl-1,3-benzoxazole→2-(3,5-Dichlorophenyl)benzo[d]oxazole-6-carboxylic acid→4-Oxocyclohexanecarboxylic acid ethyl ester→Ethyl 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.